Search  in | Advanced
   Print  

CMS Releases Final Outpatient Rule and Payment Rates for Blood and Blood Products

 

The Centers for Medicare and Medicaid Services (CMS) recently announced its final 2007 payment rates for blood and transfusion, bone marrow and hematopoietic stem cell related services provided in the outpatient setting. The rates, which take effect Jan. 1, 2007, were published in the agency’s hospital outpatient prospective payment system (HOPPS) rule for calendar year 2007.

 

AABB had submitted comments to CMS regarding this rule, specifically noting concerns regarding Medicare’s proposed payment for leukocyte-reduced red blood cells (RBCs) and other frequently transfused blood products. In the comments, AABB noted that CMS’ proposed 2007 payment for leukocyte-reduced RBCs was only $176. In contrast, the U.S. Department of Health and Human Services (HHS) recently published nationwide data in the 2005 Nationwide Blood Collection and Utilization Survey Report indicating that the average hospital payment for leukocyte-reduced RBCs in 2004 was already $201.07 – 13.6 percent higher than the proposed 2007 payment. AABB recommended that CMS base its outpatient payment rate for this product on the 2004 HHS cost data increased by 10 percent (due to inflationary costs and the introduction of new blood safety measures), or $221.18.  However, in the final rule, CMS failed to increase its proposed payments for leukocyte-reduced RBCs or other frequently transfused components. 

 

The following tables list Medicare’s 2007 payment rates for blood components as well as transfusion, bone marrow and hematopoietic progenitor cell (HPC) related procedures. 

 

Payments for Blood Components

HCPCS

APC

Product/Service

2006 Final Payment Rate

2007 Final Payment Rate

% Change

P9010

0950

Blood (whole) for transfusion

$118.04

$131.98

11.8%

P9012

0952

Cryoprecipitate

$47.15

$48.59

3.1%

P9016

0954

RBCs, leukocytes reduced

$163.33

$175.74

7.6%

P9017

9508

Plasma 1 donor frz w/in 8 hr

$70.47

$70.21

-0.4%

P9019

0957

Platelet Concentrate

$51.55

$58.95

14.4%

P9020

0958

Platelet Rich Plasma

$277.73

$209.29

-24.6%

P9021

0959

Red Blood Cells

$121.61

$129.53

6.5%

P9022

0960

Washed Red Blood Cells

$189.42

$211.03

11.4%

P9023

0949

Frozen plasma, pooled, sd

$76.23

$57.45

-24.6%

P9031

1013

Platelets leukocyte reduced

$98.41

$95.08

-3.4%

P9032

9500

Platelets irradiated

$86.64

$129.57

49.6%

P9033

0968

Platelets leukocyte reduced irradiated

$150.74

$125.33

-16.9%

P9034

9507

Platelets, pheresis

$434.48

$452.93

4.3%

P9035

9501

Plaetlet pheres leukoreduced

$493.66

$488.74

-1.0%

P9036

9502

Platelet pheresis irradiated

$326.22

$418.52

28.3%

P9037

1019

Plate pheres leukoreduced irradiated

$581.64

$617.40

6.2%

P9038

9505

RBC irradiated

$147.63

$197.00

33.4%

P9039

9504

RBC deglycerolized

$343.81

$358.31

4.2%

P9040

0969

Red blood cell leukocyte reduced irradiated

$218.27

$217.56

-0.3%

P9043

0956

Plasma Protein Fraction, 5%, 50ml

$68.02

$51.26

-24.6%

P9048

0966

Plasmaprotein fract, 5%, 250ml

$316.05

$238.16

-24.6%

P9050

9506

Granulocytes, pheresis unit

$995.72

$750.36

-24.6%

P9051

1010

Blood, l/r, cmv-neg

$207.95

$156.70

-24.7%

P9052

1011

Platelets, hla-m, l/r

$610.14

$671.72

10.1%

P9054

1016

Blood, l/r, froz/degly/wash

$262.21

$211.05

-19.5%

P9055

1017

Plt, aph/pher,l/r, cmv-neg

$526.57

$396.81

-26.4%

P9056

1018

Blood, l/r, irradiated

$178.56

$144.28

-19.2%

P9057

1021

RBC, frz/deg/wsh, l/r, irradiated

$345.91

$496.21

43.5%

P9058

1022

RBC, l/r, cmv-neg, irradiated

$267.18

$262.18

-1.9%

P9059

0955

Plasma, frozen w/in 8-24 hr

$74.78

$76.77

2.7%

P9060

9503

Fr frz plasma donor retested

$94.82

$74.49

-21.4%

 

 

Payments for Blood, Bone Marrow and HPC Related Services

APC

Service

CPT/HCPCS

2006 Final Payment Rate

2007 Final Payment Rate

% Change

0003

Bone Marrow Biopsy/Aspiration

38220, 38221

$159.23

$147.59

-7.3%

0110

Transfusion

36430, 36440, 36450, 36455, 36460, 38999,

G0267

$216.73

$212.58

-1.9%

0111

Blood Product Exchange

36511, 36512 , 36513

36514, 38205, 38206,

38242

$718.70

$720.00

0.2%

0112

Apheresis, Photopheresis, and Plasmapheresis

36515, 36516, 36522

$1569.60

$1857.75

18.4%

0123

Bone Marrow Harvesting and Bone Marrow/Stem Cell Transplant

38230, 38240, 38241

 

$1456.95

$1251.38

-14.1%

0342

Level I Pathology

 

80502, 81099, 84999, 85999, 86849, 87999. 88199, 88299, 88314, 88399, 89240

$8.63

 

$ 5.06

 

-41.4%

 

0343

Level III Pathology

 

85097, 86078, 88112, 88172, 88173, 88182, 88189, 88304, 88305, 88319, 88323, 88331, 88333, 88342, 88346

88347, 88355, 88360, 88385, 89049, 89220

$27.10

 

32.03

 

18.2%

0344

Level IV Pathology

88307, 88309, 88325, 88356, 88358, 88361, 88362, 88365, 88367, 88368, 88386

$45.13

$48.73

8.0%

0345

Level I Transfusion Laboratory Procedures

 

86850, 86903, 86905,

86906, 86921, 86923, 86927, 86945, 86950, 86960, 86970, 86971, 86976, 86985, 86999

$12.91

 

$13.39

 

3.7%

0346

Level II Transfusion Laboratory Procedures

 

86860, 86870, 86891, 86904, 86920, 86922, 86965, 86972, 86975, 86977, 86978

$19.72

 

$21.42

 

8.6%

0347

Level III Transfusion Laboratory Procedures

 

86890, 86930, 86931,

86932

$49.05

 

$45.63

 

-6.9%

0433

Level II Pathology

80500, 86077, 86079, 88104, 88106, 88107, 88108, 88125, 88160, 88161, 88162, 88184, 88185, 88187, 88188, 88300, 88302, 88311, 88312, 88313, 88318, 88321, 88329, 88332, 88334, 88384, 89230

$14.84

$15.72

5.9%

 

Overall, hospital outpatient departments will receive a 3.4 percent market basket update to Medicare payment rates for outpatient services in 2007. According to the American Hospital Association (AHA), hospitals receive “only 87 cents for every dollar of outpatient care they provide to America’s seniors.” 

 

However, AHA has praised CMS for delaying until 2009 its proposed reduction in payment updates if a facility failed to report data on quality of care.  Straying from its earlier proposal, the agency announced that it will implement separate quality measures specifically for the outpatient setting. 

Last modified on 2/23/2007 8:48:21 AM
What's New!
AABB Weekly Report - March 12, 2010
Details
National Hemovigilance Program Launches to Track Adverse Events Associated with Blood Transfusion
Details
AABB Statement on XMRV Task Force
Details
Updated Circular of Information for Cellular Therapy Products
Details
Association Bulletin #10-01 - Association Bulletin Listings
Details
Current U.S. Blood Supply is Adequate to Handle Demands Resulting from Earthquake in Haiti
Details
Emerging Infectious Disease Agents
Details
Study Highlights Implications Of Influenza Pandemics On Blood Supplies
Details
Cellular Therapies Subsections
Details
Association Bulletin #09-08 - ISBT 128 Conditional Accreditation Status
Details
AABB Launches Facebook Fan Page
Details